Cytomegalovirus Infections
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Cytomegalovirus Spread and Reactivation in Blood Cells
A National Heart, Lung, and Blood Institute–funded clinical trial investigating cytomegalovirus spread and reactivation in blood cells has c…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients [Phase 4]
A Phase 4 clinical trial evaluated using low-dose sirolimus with tacrolimus in elderly kidney transplant patients; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: An Observational Study of Valcyte (Valganciclovir) in D+/R- Liver Transplant Recipients
An observational study evaluating valganciclovir (Valcyte) for cytomegalovirus infections in D+/R- liver transplant recipients completed, wi…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. [Phase 1]
Phase 1 relative bioavailability study of Valcyte (valganciclovir) in lung transplant recipients with or without cystic fibrosis; results ha…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients [Phase 3]
Phase 3 trial comparing maribavir to oral ganciclovir for CMV disease prevention in liver transplant recipients has completed with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients [Phase 3]
Phase 3 trial evaluating prophylactic maribavir to prevent CMV disease in stem cell transplant recipients has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Evaluation of the Artus® CMV PCR Test
This update reports on a completed clinical trial evaluating the Artus CMV PCR Test for cytomegalovirus infections, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody [Phase 1]
A Phase 1 safety study of a human anti-Cytomegalovirus monoclonal antibody sponsored by Theraclone Sciences has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Valganciclovir to Reduce T Cell Activation in HIV Infection [Phase 4]
A Phase 4 trial evaluating valganciclovir to reduce T cell activation in HIV infection has completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-07-23Clinical Trial Update: Trial of Preemptive Treatment With Oral Valganciclovir Compared With Intravenous (IV) Ganciclovir for Cytomegalovirus Infection After Bone Marrow or Peripheral Blood Stem Cell Transplant [Phase 3]
Phase 3 trial comparing preemptive oral valganciclovir to intravenous ganciclovir for cytomegalovirus infections after bone marrow or periph…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. [Phase 3]
A Phase 3 trial tested whether valganciclovir prevents cytomegalovirus infections in bone marrow/stem cell transplant recipients. The study …
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Neonatal CMV-Ganciclovir Follow-up Study
A completed follow-up clinical trial evaluating ganciclovir for neonatal cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Artesunate in Preemptive Treatment of Human Cytomegalovirus (CMV) in Stem Cell Transplant Recipients [Phase 3]
Phase 3 trial evaluating artesunate for preemptive treatment of cytomegalovirus infection in stem cell transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
This completed clinical trial evaluated factors associated with cytomegalovirus disease in solid organ transplant recipients.
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus [Phase 3]
A Phase 3 trial evaluating valganciclovir for recurrent cytomegalovirus-associated inflammatory bowel disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections [Phase 2]
A Phase 2 clinical trial evaluated the effects of hormone therapy on immune function in postmenopausal women with chronic infections, and th…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Immune Response to Cytomegalovirus
The document reports the completion/update of an NHLBI-sponsored clinical trial studying immune responses to cytomegalovirus infections.
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial [NA]
Open randomized trial assessing the impact of intensive education and coaching on adherence to oral ganciclovir for CMV prophylaxis.